[ad_1]
Ranitidine products in Ireland were previously recalled in 2019
Following the recall of Ranitidine products in Ireland in 2019, Clonmel Healthcare is delighted to announce the re-introduction of Famotidine Clonmel 20mg and 40mg film-coated tablets, available on prescription to the Irish market.
Famotidine Clonmel is a H2-receptor antagonist indicated for the following:
- Prevention of recurrent duodenal ulcers*
- Duodenal ulcer
- Benign gastric ulcer
- Zollinger-Ellison-Syndrome
- Symptomatic treatment of mild reflux oesophagitis*
- Treatment of mild to moderate reflux oesophagitis**
Famotidine Clonmel is available on all reimbursement schemes including the GMS. The GMS codes are below:
- Famotidine Clonmel 20mg Film-coated Tablets x 60: 44452
- Famotidine Clonmel 40mg Film-coated Tablets x 30: 44453
Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie.
Medicinal product subject to medical prescription.
Please contact Clonmel Healthcare on 01 620 4000 if you require any additional information.
*Refer to 20 mg SmPC. **Refer to 40 mg SmPC.
PA 126/344/001-2. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: March 2022. 2022/ADV/FAM/068H.
[ad_2]
Source link